JESSICA JACOBSON: Open Payments
NPI 1811541543 · MARION, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 42 payments from 12 companies in 2025. Trend: 2023 $443 · 2024 $2,027 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $182 |
| PFIZER INC. | 10 | $157 |
| Novo Nordisk Inc | 4 | $74 |
| Lilly USA, LLC | 3 | $53 |
| Astellas Pharma US Inc | 2 | $51 |
| Vertex Pharmaceuticals Incorporated | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Medtronic, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| CooperSurgical, Inc. | 1 | $16 |
Products named: NURTEC ODT, VRAYLAR, Wegovy, Veozah, JOURNAVX, GEMTESA, ZEPBOUND, BOTOX.
Industry payments across IA — which companies pay providers there.
